Literature DB >> 17317582

Survival and function of MiHA epitope-specific host CD8 TM cells following ablative conditioning and HCT.

Alwi M Shatry1, Derry C Roopenian, Robert B Levy.   

Abstract

Memory T cell (TM) populations specific for transplantation Ags may arise from sensitization due to blood transfusions, tissue transplants, or in multiparous females. In each of these scenarios, TM cells are likely generated, and have been shown to persist in such individuals for extended time periods. Heightened resistance to allogeneic marrow engraftment in certain individuals is therefore consistent with the presence of antidonor TM. CD8 TM were generated against a single minor H Ag (MiHA) epitope to determine if such cells could inhibit allogeneic marrow engraftment. The present results demonstrate that B6 mice sensitized to a single immunodominant (H60) epitope efficiently reject donor marrow allografts expressing this MiHA alone or together with multiple minor transplantation antigens, even following ablative TBI conditioning. To further address the survival and function of these CD8 TM, sensitized mice were ablatively conditioned and administered a syngeneic HCT. CD8(+)H60(TCR+) TM were clearly detected up to 2 weeks later in such recipients. Additionally, the memory cells present were capable of mediating effector responses as evidenced by their ability to resist a second, allogeneic HCT. In summary, these observations highlight the increased risk of resistance in the presence of antidonor antigen-specific CD8 TM due to their ability to survive and function even following rigorous conditioning and HCT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17317582      PMCID: PMC1868469          DOI: 10.1016/j.bbmt.2006.12.440

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  28 in total

1.  Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells.

Authors:  J M Grayson; A J Zajac; J D Altman; R Ahmed
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

2.  Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance.

Authors:  M A Williams; J T Tan; A B Adams; M M Durham; N Shirasugi; J K Whitmire; L E Harrington; R Ahmed; T C Pearson; C P Larsen
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

3.  MiHA reactive CD4 and CD8 T-cells effect resistance to hematopoietic engraftment following reduced intensity conditioning.

Authors:  Z F Zimmerman; R B Levy
Journal:  Am J Transplant       Date:  2006-06-22       Impact factor: 8.086

4.  Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo.

Authors:  Jason M Grayson; Laurie E Harrington; J Gibson Lanier; E John Wherry; Rafi Ahmed
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

5.  Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.

Authors:  A Diefenbach; E R Jensen; A M Jamieson; D H Raulet
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

6.  A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells.

Authors:  Young-Ik Son; Shin-ichi Egawa; Tomohide Tatsumi; Richard E Redlinger; Pawel Kalinski; Tatsuya Kanto
Journal:  J Immunol Methods       Date:  2002-04-01       Impact factor: 2.303

7.  Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others.

Authors:  E Y Choi; Y Yoshimura; G J Christianson; T J Sproule; S Malarkannan; N Shastri; S Joyce; D C Roopenian
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

8.  Cytotoxically impaired transplant recipients can efficiently resist major histocompatibility complex--matched bone marrow allografts.

Authors:  M Jones; M Komatsu; R B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2000       Impact factor: 5.742

9.  Immunization to minor histocompatibility antigens on transfused RBCs through crosspriming into recipient MHC class I pathways.

Authors:  James C Zimring; Gregory A Hair; Seema S Deshpande; John T Horan
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

10.  Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1*0901.

Authors:  K Fleischhauer; E Zino; B Mazzi; E Sironi; P Servida; E Zappone; E Benazzi; C Bordignon
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

View more
  3 in total

1.  Coronary artery disease from isolated non-H2-determined incompatibilities in transplanted mouse hearts.

Authors:  Paul S Russell; Catharine M Chase; Joren C Madsen; Tsutomu Hirohashi; Lynn D Cornell; Thomas J Sproule; Robert B Colvin; Derry C Roopenian
Journal:  Transplantation       Date:  2011-04-27       Impact factor: 4.939

2.  In situ activation and expansion of host tregs: a new approach to enhance donor chimerism and stable engraftment in major histocompatibility complex-matched allogeneic hematopoietic cell transplantation.

Authors:  Alwi Shatry; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2009-05-07       Impact factor: 5.742

3.  APC-targeted proinsulin expression inactivates insulin-specific memory CD8+ T cells in NOD mice.

Authors:  Peta Ls Reeves; Rajeev Rudraraju; Xiao Liu; F Susan Wong; Emma E Hamilton-Williams; Raymond J Steptoe
Journal:  Immunol Cell Biol       Date:  2017-06-14       Impact factor: 5.126

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.